Literature DB >> 19529957

Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy.

Marcin Barczynski1, Aleksander Konturek, Alicja Hubalewska-Dydejczyk, Stanislaw Cichon, Wojciech Nowak.   

Abstract

BACKGROUND AND AIMS: Intraoperative parathyroid hormone assay (IOPTH) has been used during minimally invasive parathyroidectomy (MIP) to predict operative success. However, the applied criteria are not equivalent in detection of multiglandular disease (MGD) and predicting cure. The purpose of this study was to evaluate the most commonly applied criteria of IOPTH in patients undergoing MIP in a tertiary referral center.
MATERIALS AND METHODS: A retrospective review of 260 patients with sporadic primary hyperparathyroidism and concordant results of sestamibi scanning and ultrasound of the neck undergoing MIP (135 video-assisted and 125 open) between Dec 2002 and May 2008, with a 6-month postoperative follow-up of intact parathyroid hormone and serum calcium levels, was performed. The main outcome measures included evaluation of predictive values of Halle, Miami, Rome, and Vienna IOPTH interpretation criteria.
RESULTS: The following overall accuracy, sensitivity, specificity, positive predictive value, and negative predictive values were found, respectively: 65%, 62.9%, 100%, 100%, and 14.2% for Halle criterion; 97.3%, 97.6%, 93.3%, 99.6%, and 70% for Miami criterion; 83.8%, 82,9%, 100%, 100%, and 26.3% for Rome criterion; and 92.3%, 92.2%, 93.3%, 99.6%, and 60.9% for Vienna criterion.
CONCLUSIONS: Miami criterion followed by Vienna criterion was found to be the best balanced among other criteria, with the highest accuracy in intraoperative prediction of cure. However, Rome criterion followed by Halle criterion was found to be the most useful in intraoperative detection of MGD. Nevertheless, their application in patients qualified for MIP with concordant results of sestamibi scanning and ultrasound of the neck would result in a significantly higher number of negative conversions to bilateral neck explorations and only a marginal improvement in the success rate of primary operations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19529957     DOI: 10.1007/s00423-009-0510-z

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  24 in total

Review 1.  Intraoperative testing for parathyroid hormone: a comprehensive review of the use of the assay and the relevant literature.

Authors:  Alexis Byrne Carter; Peter J Howanitz
Journal:  Arch Pathol Lab Med       Date:  2003-11       Impact factor: 5.534

2.  Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients.

Authors:  Bill Chiu; Cord Sturgeon; Peter Angelos
Journal:  Arch Surg       Date:  2006-05

3.  Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience.

Authors:  Clive S Grant; Geoffrey Thompson; David Farley; Jon van Heerden
Journal:  Arch Surg       Date:  2005-05

4.  Results of video-assisted parathyroidectomy: single institution's six-year experience.

Authors:  Paolo Miccoli; Piero Berti; Gabriele Materazzi; Marco Massi; Antonella Picone; Michele N Minuto
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

5.  Open minimally invasive parathyroid surgery.

Authors:  Robert Udelsman; Patricia I Donovan
Journal:  World J Surg       Date:  2004-11-04       Impact factor: 3.352

6.  Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial.

Authors:  Marcin Barczyński; Stanisław Cichoń; Aleksander Konturek; Wojciech Cichoń
Journal:  World J Surg       Date:  2006-05       Impact factor: 3.352

7.  Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases.

Authors:  Allan Siperstein; Eren Berber; German F Barbosa; Michael Tsinberg; Andrew B Greene; Jamie Mitchell; Mira Milas
Journal:  Ann Surg       Date:  2008-09       Impact factor: 12.969

8.  How does the operative strategy for primary hyperparathyroidism impact the findings and cure rate? A comparison of 800 parathyroidectomies.

Authors:  Julie McGill; Cord Sturgeon; Sharone P Kaplan; Bill Chiu; Edwin L Kaplan; Peter Angelos
Journal:  J Am Coll Surg       Date:  2008-05-19       Impact factor: 6.113

9.  Intraoperative PTH monitoring during parathyroidectomy: the need for stricter criteria to detect multiglandular disease.

Authors:  Celestino Pio Lombardi; Marco Raffaelli; Emanuela Traini; Enrico Di Stasio; Cinzia Carrozza; Carmela De Crea; Cecilia Zuppi; Rocco Bellantone
Journal:  Langenbecks Arch Surg       Date:  2008-07-24       Impact factor: 3.445

10.  Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies.

Authors:  John I Lew; Carmen C Solorzano; Raquel E Montano; Denise M Carneiro-Pla; George L Irvin
Journal:  Surgery       Date:  2008-08       Impact factor: 3.982

View more
  42 in total

1.  Current practice in the surgical management of parathyroid disorders: a United Kingdom survey.

Authors:  K Varadharajan; N Choudhury
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-08-17       Impact factor: 2.503

2.  Primary hyperparathyroidism: an analysis of failure of parathyroidectomy.

Authors:  A Bagul; H P Patel; D Chadwick; B J Harrison; S P Balasubramanian
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

Review 3.  Primary hyperparathyroidism.

Authors:  Tarıq Madkhali; Amal Alhefdhi; Herbert Chen; Dawn Elfenbein
Journal:  Ulus Cerrahi Derg       Date:  2016-03-01

4.  The final intraoperative parathyroid hormone level: how low should it go?

Authors:  Laura I Wharry; Linwah Yip; Michaele J Armstrong; Mohamed A Virji; Michael T Stang; Sally E Carty; Kelly L McCoy
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

5.  Risk factors for "PTH spikes" during surgery for primary hyperparathyroidism.

Authors:  Philipp Riss; Christoph Krall; Christian Scheuba; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2013-07-05       Impact factor: 3.445

6.  Intraoperative parathyroid hormone testing in primary hyperparathyroidism surgery: time for giving up?

Authors:  Paola Vincenza Sartori; Alberto Maria Saibene; Ennio Leopaldi; Marco Boniardi; Edoardo Beretta; Samuele Colombo; Emanuela Morenghi; Juliana Pauna; Loredana De Pasquale
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-10-24       Impact factor: 2.503

7.  Contemporary surgical treatment of primary hyperparathyroidism without intraoperative parathyroid hormone measurement.

Authors:  O A Mownah; G Pafitanis; W M Drake; J N Crinnion
Journal:  Ann R Coll Surg Engl       Date:  2015-11       Impact factor: 1.891

8.  Factors that influence parathyroid hormone half-life: determining if new intraoperative criteria are needed.

Authors:  Andrew J Leiker; Tina W F Yen; Dan C Eastwood; Kara M Doffek; Aniko Szabo; Douglas B Evans; Tracy S Wang
Journal:  JAMA Surg       Date:  2013-07       Impact factor: 14.766

9.  Successful minimally invasive surgery for primary hyperparathyroidism: influence of preoperative imaging and intraoperative parathyroid hormone levels.

Authors:  Gaëtan-Romain Joliat; Nicolas Demartines; Luc Portmann; Ariane Boubaker; Maurice Matter
Journal:  Langenbecks Arch Surg       Date:  2015-11-21       Impact factor: 3.445

10.  Minimally invasive parathyroidectomy with or without intraoperative parathyroid hormone for primary hyperparathyroidism.

Authors:  Hyun Gu Kim; Woo Young Kim; Sang Uk Woo; Jae Bok Lee; Yu-Mi Lee
Journal:  Ann Surg Treat Res       Date:  2015-08-24       Impact factor: 1.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.